Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
Delayed Quote. Delayed Nyse - 11/26 01:10:00 pm
109.52 USD   -4.34%
11/24INSIDER BUY : Edwards Lifesciences
MT
11/22INSIDER SELL : Edwards Lifesciences
MT
11/10INSIDER SELL : Edwards Lifesciences
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Edwards Lifesciences

10/11/2021 | 09:22am EST


© MT Newswires 2021
All news about EDWARDS LIFESCIENCES CORPORATION
11/24INSIDER BUY : Edwards Lifesciences
MT
11/22INSIDER SELL : Edwards Lifesciences
MT
11/10INSIDER SELL : Edwards Lifesciences
MT
11/08INSIDER SELL : Edwards Lifesciences
MT
11/06Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement Program
PR
11/06Edwards Lifesciences Corporation Announces Six-Month Data from Transcatheter Tricuspid ..
CI
11/05TAVR with SAPIEN 3 Demonstrated as Economically Dominant Treatment Strategy Compared to..
PR
10/29EDWARDS LIFESCIENCES CORP Management's Discussion and Analysis of Financial Condition ..
AQ
10/29TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 5, 2021.
CI
10/29TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 8, 2019.
CI
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Financials (USD)
Sales 2021 5 264 M - -
Net income 2021 1 426 M - -
Net cash 2021 1 335 M - -
P/E ratio 2021 47,7x
Yield 2021 -
Capitalization 68 377 M 68 377 M -
EV / Sales 2021 12,7x
EV / Sales 2022 11,3x
Nbr of Employees 14 900
Free-Float 96,6%
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | EW | US28176E1082 | MarketScreener
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 109,52 $
Average target price 121,30 $
Spread / Average Target 10,8%
EPS Revisions
Managers and Directors
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
Nicholas J. Valeriani Independent Director
Kieran Thomas Gallahue Independent Director
Sector and Competitors